Dynavax Technologies Corp DVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:10 PM EST
11.39quote price arrow up+0.01 (+0.09%)
Volume
700,970
52 week range
7.26 - 17.48
Loading...
  • Open11.30
  • Day High11.41
  • Day Low11.05
  • Prev Close11.38
  • 52 Week High17.48
  • 52 Week High Date08/10/22
  • 52 Week Low7.26
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap1.453B
  • Shares Out127.58M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change6.39

KEY STATS

  • Open11.30
  • Day High11.41
  • Day Low11.05
  • Prev Close11.38
  • 52 Week High17.48
  • 52 Week High Date08/10/22
  • 52 Week Low7.26
  • 52 Week Low Date05/12/22
  • Market Cap1.453B
  • Shares Out127.58M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change6.39

RATIOS/PROFITABILITY

  • EPS (TTM)2.01
  • P/E (TTM)5.68
  • Fwd P/E (NTM)-138.90
  • EBITDA (TTM)306.11M
  • ROE (TTM)112.87%
  • Revenue (TTM)733.26M
  • Gross Margin (TTM)64.72%
  • Net Margin (TTM)44.35%
  • Debt To Equity (MRQ)44.21%

EVENTS

  • Earnings Date02/27/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Dynavax Technologies Corp

Profile

MORE
Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company that is focused on developing and commercializing vaccines. The Company's products include HEPLISAV-B and CpG 1018. The HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose hepatitis B vaccine for adults. HEPLISAV-B is a sterile solution for injection presented in 0.5 mL single-dose...
Scott Myers
Independent Chairman of the Board
Ryan Spencer
Chief Executive Officer, Director
David Novack
President, Chief Operating Officer
Kelly MacDonald CPA
Chief Financial Officer, Senior Vice President
Address
2100 Powell Street, Suite 720
Emeryville, CA
94608
United States

Top Peers

SYMBOLLASTCHG%CHG
MYGN
Myriad Genetics Inc
19.97+0.25+1.27%
RCUS
Arcus Biosciences Inc
22.47+0.84+3.88%
RGNX
Regenxbio Inc
23.50+0.29+1.25%
NVTA
Invitae Corp
2.39+0.03+1.27%
ITOS
Iteos Therapeutics Inc
21.43+0.53+2.54%